CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review
|<<... 3 4 5 6 7 8 9 ...>>|

Original Research

JOURNAL：CBSMD Article Link

Atrial Fibrillation and the Risk of Heart Failure

CBSMD

Pre-reading

Atrial Fibrillation and the Risk of Heart Failure


June, 2018 "Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure" pointed out patients with a pacemaker or defibrillator, short-lasting, subclinical atrial fibrillation (SCAF) progression was strongly associated with HF hospitalization.



In a nationally representative cohort, US National Readmissions Database, which collects data from 22 states. There were 60,203 adults who underwent CA of AF. The primary endpoint was early mortality, defined as mortality either during the index ablation hospitalization or during 30-day rehospitalizations. Early mortality following AF ablation affected nearly 1 in 200 patients, with the majority of deaths occurring during 30-day readmission. Procedural complications, congestive heart failure, and low hospital AF ablation volume were predictors of early mortality. Prompt management of post-procedure complications and CHF may be critical for reducing mortality rates following AF ablation. The mortality rate reported in this study is likely to be an underestimate, because deaths that occurred outside the hospital or in a state other than the one in which the index ablation procedure was performed were not accounted for in the National Readmissions Database. In addition to early identification and treatment of a complication and HF, the data suggest that mortality also could be improved by restricting low-volume hospitals from performing AF CA procedures in the absence of an experienced proctor.


1. Screening for Atrial Fibrillation With ECG: USPSTF Recommendation

2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

>CBS CBS 2019

> CBS 2019 REGISTRATION

> CBS 2019 PROGRAM

> CBS 2019 CALL FOR SCIENCE

> CBS 2019 SPOTLIGHTS

 CBSMD

> CBSMD WEBSITE REGISTRATION

> EDUCATION CENTER

> RECOMMANDED PAPER

> TOP 10 RESEARCH PAPER

> PRE-READING

CBS 2019 CBS 2019 FACULTY Education Resource CBSMD Scientific Library
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top